George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So Madabout what haven't I understood, please enlighten me.
Quote from the RNS 12th March: Purusant to the two previous conversions announced on 9 February 2024 and 28 February 2024, a total of 1,324,484 Ordinary shares have been converted and sold by Macquarie Bank/CLG which represents 13% of all trading volume in the market during the month of February 2024.
Furthermore, Macquarie Bank/CLG have agreed to no further conversions for the month of March unless price and volumes reach certain agreed higher thresholds.
From RNS 22nd March: At the time of the Dermatonics acquisition, the Convertible Bond Facility was the best option for raising finance; however, now that we have secured an accretive target and thus generate significantly greater revenue the Board now has the possibility of securing alternative, more traditional financing instruments and has come to an amicable agreement with CLG Capital (and by proxy, Macquarie Bank) not to utilise the Facility any further.
You also don't need to get personal, it weakens your argument.
GLA
Bazzaman, what a ridiculous post. The only thing that hangs over this company and its potential is the loan note. You clearly haven’t got a clue what you’re talking about. Grow up
What's your alternative funding Stuart? More empty promises and in the meantime, now we are in April, cln can sell the crap out of the SP sending it down again. They promised no more sells in March which you thought was great but you missed the deadline, yet again, to get alternative funding. You really don't have a clue how to run this company, so run along and let somebody more worthy run it for half your salary.
GLA
Haven't suggested that at all PG, if you read my response properly there is one statement re future financing and a separate statement about the merits of the acquisition already made
I agree. However, if it is used as a debt structure for refinancing, perhaps its a good punt. This sort of thing goes over my head if im honest.
Thats me told. Fair enough.
Are you suggesting Sbtx will be hocking the modi internal sales figures to proposed lenders, figures not known to the market? Thats a stretch. Have you thought this through before telling me to think? If i understand you correctly, you are implying the sales estimates are significant enough to be leveraged as debt. If they figures are significant then is this not price sensitive and we should be informed?
Surely we don’t want any more acquisitions before the Croda news
PG, just think will you, the acquisition was lined up and good to go but as SA told us by RNS and reinforced at the Investor Meets, "The Board also announces that it has decided to seek alternative financing options for its inorganic acquisition strategy, rather than drawing upon the Facility any further.". So until that alternative financing is in place there will not be any additional acquisitions.
The figures for the Umesh Modi launch and NHS Dermatonic's Once Heel Balm sales growth will determine whether SA was right to dilute via the loan in order to secure this initial acquisition, the other near term acquisition target we were informed was a manufacturer, so less time critical.
That the board manage to take advantage of a sudden rise such as the one we had last week and issue a positive rns that helps momentum. Instead we have another deadline miss by the man that claims he never set himself up for failure. And here we are, several deadlines missed. Or im confused about the second acquisition is due any time in 2024 and not by the end of the first quarter. Maybe the plan is to set a deadline and miss it by around 6 weeks.
Re pompey, see note 28th march about taking something off the table. just happens every time on any jam tomorrow stock.
Great products but sales struggling.
Looks like the sell down is back in full flow from the cln
No Farris, he has moved on apparently. The timelines since the Manchester meet have shown that he was probably employed somewhat prematurely for the creation of own brand products and/or shampoo and toothpaste. But we’re on the cusp of the exciting times now, good things come to those who wait!
That was back in the day when the share price was 60-70 pence
The good old days.
Does the shampoo guy still work for Sbtx think he made he’s debut at the Manchester meet?
I’m more comfortable now then a month ago, obviously due to the price rise and especially since the last RNS and chat from SA. If you were a new buyer into this company right now I wouldn’t think you could believe what you are getting on the plate for the price. I’m annoyed at myself for not getting more when the rise started last week and hovered over the buy button about 5o times. The wife has already warned me no more and would go mad even if I came out with a profit?
I'm happy to pay for Elric's analysis and have also added during the last few days but I'm also entitled to my view that the jury is still out on SA.
BOL
Hi Pompey,
I am still looking for concrete evidence from the company. I love the products, but so far sales to 500 or so retendered customers , 100 plus of which stayed from the "trial" is terrible. Perhaps we should start a new 20,000 customer trial as well, to really get sales moving.
forget how tasty the "jam", is, just see the hard numbers and couple it with the amount of times we have seen prices shoot up then retreat stunningly. Why I believe taking some profit on any gains a shrewd move. it then gives you options later on.
Really glad to see some investors up, but its only a very small percentage.
Bazzman, it is precisely comments like this that stop listed CEOs from communicating with the market at all. Why would anyone give a timeline to a bunch of baying wolves? SA said that "if I can get the lawyers pens to move fast enough, I hope to get a deal done by year end" He missed this by three weeks and the market called him worse than muck for that. There's no way he's going to give you another hard timeline. Why should he? He gave a solid account of progress to date in his presentation on Friday last week. The share price has doubled since that day. He has admitted that the CLN was not well received by the market. You also have to look at the external influences to all of this. Why are you not blaming Tom Winnifrith and the rest of the trolls for the drop? I've used the drop in SP to lower my average. That strategy has worked extremely well over the last five trading days. A market gets the CEOs that they deserve, we had a very open and honest strategic thinker that conversed openly with the market in the past, if he makes one slight error he is torn apart for it. He's also been directly instructed not to give external interviews behind pay walls. You reap what you sow.
The CEO in his previous interviews of over promising and under delivering has not IMHO managed to transform the company by end of Q1 2024 (Easter). Two acquisitions were discussed, he was late on the first one with crap funding and the second hasn't materialised. Supporters will say give him some slack as SP is now rising but his actions caused the drop to the 6/7p level.
What are the new timescales that we can look forward to?
Acquisition 2 (April/May)
Revenue boosts from Dermatonics and Umesh Modi Group sales (???)
Croda (???)
The jury is still out on Ashman and 2024 does need to be transformational if he is to survive.
GLA
I take it you’re back in?
Unless Croda is using its huge war chest for another acquisition. they have snaffled a few good companies over the past few years.
Well done researcher, great to see this rise. nothing wrong with taking a little off the table when up.
A top slice due, I have £25K profit....
The more green filters I see, the higher the SP.
GLA
Very good Gibson